September 27, 2020

The Niche

Knoepfler lab stem cell blog

Poll: How do you feel about ‘pay-to-play’ clinical trials?

There’s a growing trend whereby patients have to pay to be in a clinical trial. This is now widely referred to as “pay-to-play”.

pay-to-play
photographer unknown

Proponents of this idea point toward potential benefits in the form of patients gaining access to innovative therapies. They also argue that this approach provides a much-needed funding mechanism for the trials and that it could lead to more insurance coverage of therapies in development.

Opponents of pay-play-play argue it is unethical to require a patient to pay (sometimes large sums of money) to be a guinea pig to get a still experimental therapy that could do no good or even do harm. They also point to the risk that pay-to-play encourages more fly-by-night operations such as the dubious clinics in the stem cell field.

Is play-to-play worth the potential risks? Is it a trap? Is it instead liberating and helpful to patients?

What do you think? Take our poll and weigh in via the comments section.

%d bloggers like this: